Document Detail


Personalized cancer medicine and the future of pathology.
MedLine Citation:
PMID:  22143935     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
In February 2011, a group of pathologists from different departments in Europe met in Zurich, Switzerland, to discuss opportunities and challenges for pathology in the era of personalized medicine. The major topics of the meeting were assessment of the role of pathology in personalized medicine, its future profile among other biomedical disciplines with an interest in personalized medicine as well as the evolution of companion diagnostics. The relevance of novel technologies for genome analysis in clinical practice was discussed. The participants recognize that there should be more initiatives taken by the pathology community in companion diagnostics and in the emerging field of next-generation sequencing and whole genome analysis. The common view of the participants was that the pathology community has to be mobilized for stronger engagement in the future of personalized medicine. Pathologists should be aware of the challenges and the analytical opportunities of the new technologies. Challenges of clinical trial design as well as insurance and reimbursement questions were addressed. The pathology community has the responsibility to lead medical colleagues into embracing this new area of genomic medicine. Without this effort, the discipline of pathology risks losing its key position in molecular tissue diagnostics.
Authors:
H Moch; P R Blank; M Dietel; G Elmberger; K M Kerr; J Palacios; F Penault-Llorca; G Rossi; T D Szucs
Related Documents :
22101695 - Complementary and alternative medicine in rheumatoid arthritis.
21951445 - Ethics, law and paediatric medicine.
21831105 - Factors that facilitate and hinder the manageability of living with amyotrophic lateral...
22141385 - Use of herbal medicines and nutritional supplements in ocular disorders: an evidence-ba...
21889075 - Attitudes, awareness, and barriers toward evidence-based practice in orthodontics.
20610315 - Tocilizumab: therapy and safety management.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-6
Journal Detail:
Title:  Virchows Archiv : an international journal of pathology     Volume:  -     ISSN:  1432-2307     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423843     Medline TA:  Virchows Arch     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, CH-8091, Zurich, Switzerland, holger.moch@usz.ch.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of...
Next Document:  Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing ...